NCT05204147 2026-04-22
Actinium 225 Labeled Anti-CEA Antibody (Ac225-DOTA-M5A) for the Treatment of CEA Producing Advanced or Metastatic Cancers
City of Hope Medical Center
Phase 1 Suspended
Clinical Trials
17 trialsNCT05372614 2026-04-14
Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene
National Cancer Institute (NCI)
Phase 1 Suspended
NCT05554380 2026-04-13
Study of Chemotherapy Plus Ipatasertib for People With Solid Tumors With PTEN/AKT Mutations, A ComboMATCH Treatment Trial
National Cancer Institute (NCI)
Phase 2 Suspended
NCT06211933 2026-02-12
PULS
Centre Leon Berard
Phase 1/2 Suspended
NCT05351294 2026-01-07
Assessment of Early Radiation Oncology Involvement Alongside Standard Oncologic Care in the Managemet
Rutgers, The State University of New Jersey
Phase 3 Suspended
NCT03568292 2025-11-17
Virtual Reality in Reducing Pain and Anxiety in Cancer Participants Undergoing Painful Procedures
University of Southern California
Phase NA Suspended
NCT02130492 2025-10-23
A Pilot Study Treatment of Malignant Tumors Using [18F] Fluorodeoxyglucose (FDG)
Weill Medical College of Cornell University
Phase 1/2 Suspended
NCT02354547 2025-05-30
A Study of SGT-53 in Children With Refractory or Recurrent Solid Tumors
SynerGene Therapeutics, Inc.
Phase 1 Suspended
NCT06147505 2024-10-29
XS005 Injection Combined With Stupp Regimen for Adjuvant Chemotherapy in Subjects With Primary Glioblastoma(GBM)
Dushu Lake Hospital Affiliated to Soochow University
Phase 1/2 Suspended
NCT01562626 2021-05-12
Phase I/II Study of APS001F With Flucytosine and Maltose in Solid Tumors
Anaeropharma Science, Inc.
Phase 1/2 Suspended
NCT00991601 2010-10-13
Ultra Sound Guided Fine Needle Aspiration Cytology (FNAC) of Liver and Pancreas Tumours
Herlev Hospital
Phase NA Suspended
NCT00868647 2009-09-01
Radiofrequency Ablation (RFA) Of Tumors Acquired In Childhood
Seattle Children's Hospital
Phase 2 Suspended
NCT00459823 2009-03-24
A Dose Escalation Study of E7107 Administered IV (Bolus) on Days 1, 8, and 15 Every 28 Days to Patients With Solid Tumours
Eisai Inc.
Phase 1 Suspended
NCT00827203 2009-03-09
A Safety Study to Determine the Maximum Tolerated Dose of Elesclomol Sodium in Patients With Solid Tumors
Synta Pharmaceuticals Corp.
Phase 1 Suspended
NCT00499499 2009-02-04
A Dose Escalation Study of E7107 Administered Intravenously on Days 1 and 8 Every 21 Days to Patients With Solid Tumors
Eisai Inc.
Phase 1 Suspended
NCT00264472 2008-12-15
A Study of 5 Fluorouracil and the Anti-Tumor Activity of ADH300004 and 5 Fluorouracil in Subjects With Incurable Solid Tumors
Adherex Technologies, Inc.
Phase 1 Suspended
NCT00460278 2008-06-04
Study of XL418 in Adults With Solid Tumors
Exelixis
Phase 1 Suspended